Top

Published in:

01-11-2013 | Review Article

“Mini” Gastric Bypass: Systematic Review of a Controversial Procedure

Authors: Kamal K. Mahawar, Neil Jennings, James Brown, Ajay Gupta, Shlok Balupuri, Peter K. Small

Published in: Obesity Surgery | Issue 11/2013

Abstract

Mini gastric bypass is being explored by many bariatric surgeons as a standalone bariatric procedure. Several surgeons from different parts of the world have now published their extensive experience with this procedure. It appears to be an effective bariatric procedure with acceptable weight loss, co-morbidity resolution, and complication rates in the short and medium term. Its proponents claim that it is safer and easier than the gold standard Roux-en-Y gastric bypass. However, concerns with regard to symptomatic gastric or oesophageal biliary reflux requiring revisional surgery and long-term risk of gastric and oesophageal cancers persist. This paper reviews the published experience to date with this procedure and examines the surrounding controversy.

Rutledge R. The mini-gastric bypass: experience with the first 1274 cases. Obes Surg. 2001;11(3):276–80.PubMedCrossRef

Wang W, Wei PL, Lee YC, et al. Short-term results of laparoscopic mini-gastric bypass. Obes Surg. 2005;15(5):648–54.PubMedCrossRef

Fisher BL, Buchwald H, Clark W, et al. Mini-gastric bypass controversy. Obes Surg. 2001;11(6):773–7.PubMed

Olchowski S, Timms MR, O’Brien P, et al. More on mini gastric bypass. Obes Surg. 2001;11(4):532.PubMedCrossRef

Johnson WH, Fernanadez AZ, Farrell TM, et al. Surgical revision of loop ("mini") gastric bypass procedure: multicenter review of complications and conversions to Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2007;3(1):37–41.PubMedCrossRef

Collins BJ, Miyashita T, Schweitzer M. Gastric bypass. Why Roux-en-Y? A review of experimental data. Arch Surg. 2007;142(10):1000–3.PubMedCrossRef

McQuaid KR, Laine L, Fennerty MB, et al. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther. 2011;34(2):146–65. doi:10.1111/j.1365-2036.2011.04709.x. Epub 2011 May 25.PubMedCrossRef

Gillen P, Keeling P, Byrne PJ, et al. Implication of duodenogastric reflux in the pathogenesis of Barrett’s oesophagus. Br J Surg. 1988;75(6):540–3.PubMedCrossRef

Kauer WK, Peters JH, DeMeester TR, et al. Mixed reflux of gastric and duodenal juices is more harmful to the esophagus than gastric juice alone. The need for surgical therapy re-emphasized. Ann Surg. 1995;222(4):525–31.PubMed

10.

Noun R, Zeidan S. Laparoscopic mini-gastric bypass: an effective option for the treatment of morbid obesity. J Chir (Paris). 2007;144(4):301–4 [Article in French].CrossRef

11.

Chevallier JM, Chakhtoura G, Zinzindohoué F, et al. (Paris). [Laparoscopic mini-gastric bypass]. 2009; 146(1): 60–4

12.

Copăescu C, Munteanu R, Prala N, et al. Laparoscopic mini gastric bypass for the treatment of morbid obesity. Initial experience. Chir (Bucur). 2004;99(6):529–39 [Article in Romanian].

13.

Hu XG, Zheng CZ, Ji XR, et al. Short-term outcome of laparoscopic gastric bypass and minigastric bypass on obesity patients with type 2 diabetes mellitus. Zhonghua Wei Chang Wai Ke Za Zhi. 2009;12(6):554–7 [Article in Chinese].PubMed

14.

Guo X, Yin K, Zhuo GZ et al. Efficacy comparison between 2 methods of laparoscopic gastric bypass surgery in the treatment of type 2 diabetes mellitus. Zhonghua Wei Chang Wai Ke Za Zhi. 2012; 15(11): 1125–8 [Article in Chinese].

15.

García-Caballero M, Valle M, Martínez-Moreno JM, et al. Resolution of diabetes mellitus and metabolic syndrome in normal weight 24–29 BMI patients with One Anastomosis Gastric Bypass. Nutr Hosp. 2012;27(2):623–31.PubMed

16.

Kim Z, Hur KY. Laparoscopic mini-gastric bypass for type 2 diabetes: the preliminary report. World J Surg. 2011;35(3):631–6.PubMedCrossRef

17.

Lee WJ, Ser KH, Lee YC, et al. Laparoscopic Roux-en-Y vs. mini-gastric bypass for the treatment of morbid obesity: a 10-year experience. Obes Surg. 2012;22(12):1827–34.PubMedCrossRef

18.

Lee WJ, Lee YC, Ser KH, et al. Revisional surgery for laparoscopic minigastric bypass. Surg Obes Relat Dis. 2011;7(4):486–91.PubMedCrossRef

19.

Lee WJ, Wang W, Lee YC, et al. Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI > 35 and <35 kg/m2. J Gastrointest Surg. 2008;12(5):945–52.PubMedCrossRef

20.

Lee WJ, Wang W, Lee YC, et al. Laparoscopic mini-gastric bypass: experience with tailored bypass limb according to body weight. Obes Surg. 2008;18(3):294–9.PubMedCrossRef

21.

Lee WJ, Yu PJ, Wang W, et al. Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial. Ann Surg. 2005;242(1):20–8.PubMedCrossRef

22.

Peraglie C. Laparoscopic mini-gastric bypass (LMGB) in the super-super obese: outcomes in 16 patients. Obes Surg. 2008;18(9):1126–9.PubMedCrossRef

23.

Chakhtoura G, Zinzindohoué F, Ghanem Y, et al. Primary results of laparoscopic mini-gastric bypass in a French obesity-surgery specialized university hospital. Obes Surg. 2008;18(9):1130–3.PubMedCrossRef

24.

Piazza L, Ferrara F, Leanza S, et al. A laparoscopic mini-gastric bypass: short-term single-institute experience. Updates Surg. 2011;63(4):239–42.PubMedCrossRef

25.

Carbajo M, García-Caballero M, Toledano M, et al. One-anastomosis gastric bypass by laparoscopy: results of the first 209 patients. Obes Surg. 2005;15(3):398–404.PubMedCrossRef

26.

Rutledge R, Walsh TR. Continued excellent results with the mini-gastric bypass: six-year study in 2,410 patients. Obes Surg. 2005;15(9):1304–8.PubMedCrossRef

27.

Noun R, Riachi E, Zeidan S, et al. Mini-gastric bypass by mini-laparotomy: a cost-effective alternative in the laparoscopic era. Obes Surg. 2007;17(11):1482–6.PubMedCrossRef

28.

Noun R, Skaff J, Riachi E, et al. One thousand consecutive mini-gastric bypass: short- and long-term outcome. Obes Surg. 2012;22(5):697–703.PubMedCrossRef

29.

Rutledge R. Hospitalization before and after mini-gastric bypass surgery. Int J Surg. 2007;5(1):35–40.PubMedCrossRef

30.

Begg C, Cho M, Eastwood S. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA. 1996;276(8):637–9.PubMedCrossRef

31.

Sacks BC, Mattar SG, Qureshi FG, et al. Incidence of marginal ulcers and the use of absorbable anastomotic sutures in laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2006;2(1):11–6.PubMedCrossRef

32.

Gumbs AA, Duffy AJ, Bell RL. Incidence and management of marginal ulceration after laparoscopic Roux-Y gastric bypass. Surg Obes Relat Dis. 2006;2(4):460–3.PubMedCrossRef

33.

Dallal RM, Bailey LA. Ulcer disease after gastric bypass surgery. Surg Obes Relat Dis. 2006;2(4):455–9.PubMedCrossRef

34.

McCarthy HB, Rucker RD, Chan EK, et al. Gastritis after gastric bypass surgery. Surgery. 1985;98:68–71.PubMed

35.

Scozzari G, Trapani R, Toppino M, et al. Esophagogastric cancer after bariatric surgery: systematic review of the literature. Surg Obes Relat Dis. 2013;9(1):133–42.PubMedCrossRef

36.

Babor R, Booth M. Adenocarcinoma of the gastric pouch 26 years after loop gastric bypass. Obes Surg. 2006;16(7):935–8.PubMedCrossRef

37.

Taha AS, Angerson WJ, Morran CG. Reflux and Barrett’s oesophagitis after gastric surgery—long-term follow-up and implications for the roles of gastric acid and bile in oesophagitis. Aliment Pharmacol Ther. 2003;17(4):547–52.PubMedCrossRef

38.

Nason KS, Farrow DC, Haigh G, et al. Gastric fluid bile concentrations and risk of Barrett’s esophagus. Interact Cardiovasc Thorac Surg. 2007;6(3):304–7.PubMedCrossRef

39.

Champion G, Richter JE, Vaezi MF, et al. Duodenogastroesophageal reflux: relationship to pH and importance in Barrett’s esophagus. Gastroenterology. 1994;107(3):747–54.PubMedCrossRef

40.

Theisen J, Peters JH, Fein M, et al. The mutagenic potential of duodenoesophageal reflux. Ann Surg. 2005;241(1):63–8.PubMed

41.

Lagergren J, Lindam A. The risk of oesophageal adenocarcinoma after gastrectomy for peptic ulcer disease. Eur J Cancer. 2012;48(5):749–52.PubMedCrossRef

42.

Lagergren J, Lindam A, Mason RM. Gastric stump cancer after distal gastrectomy for benign gastric ulcer in a population-based study. Int J Cancer. 2012;131(6):E1048–52.PubMedCrossRef

43.

Freedman J, Lagergren J, Bergström R, et al. Cholecystectomy, peptic ulcer disease and the risk of adenocarcinoma of the oesophagus and gastric cardia. Br J Surg. 2000;87(8):1087–93.PubMedCrossRef

44.

Lacaine F, Houry S, Huguier M. Stomach cancer after partial gastrectomy for benign ulcer disease. A critical analysis of epidemiological reports. Hepatogastroenterology. 1992;39(1):4–8.PubMed

45.

Avidan B, Sonnenberg A, Schnell TG, et al. Gastric surgery is not a risk for Barrett’s esophagus or esophageal adenocarcinoma. Gastroenterology. 2001;121(6):1281–5.PubMedCrossRef

46.

Lundegårdh G, Adami HO, Helmick C, et al. Stomach cancer after partial gastrectomy for benign ulcer disease. N Engl J Med. 1988;319(4):195–200.PubMedCrossRef

47.

Fisher SG, Davis F, Nelson R, et al. A cohort study of stomach cancer risk in men after gastric surgery for benign disease. J Natl Cancer Inst. 1993;85(16):1303–10.PubMedCrossRef

48.

Birgisson S, Rice TW, Easley KA, et al. The lack of association between adenocarcinoma of the esophagus and gastric surgery: a retrospective study. Am J Gastroenterol. 1997;92(2):216–21.PubMed

49.

Nishijima K, Miwa K, Miyashita T, et al. Impact of the biliary diversion procedure on carcinogenesis in Barrett’s oesophagus surgically induced by duodenoesophageal reflux in rats. Ann Surg. 2004;240(1):57–67.PubMedCrossRef

50.

Freedman J, Ye W, Näslund E, et al. Association between cholecystectomy and adenocarcinoma of the esophagus. Gastroenterology. 2001;121(3):548–53.PubMedCrossRef

51.

Lorusso D, Pezzolla F, Linsalata M, et al. Duodenogastric reflux and gastric mucosal cell proliferation after cholecystectomy or Billroth II gastric resection. Gastroenterol Clin Biol. 1994;18(11):927–31.PubMed

52.

Hansson LE, Nyrén O, Hsing AW, et al. The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med. 1996;335(4):242–9.PubMedCrossRef

53.

Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1(8390):1311–5.PubMedCrossRef

54.

Moose D, Lourie D, Powell W, et al. Laparoscopic Roux-en-Y gastric bypass: minimally invasive bariatric surgery for the superobese in the community hospital setting. Am Surg. 2003;69(11):930–2.PubMed

55.

Wang W, Huang MT, Wei PL, et al. Laparoscopic mini-gastric bypass for failed vertical banded gastroplasty. Obes Surg. 2004;14(6):777–82.PubMedCrossRef

56.

Noun R, Zeidan S, Riachi E, et al. Mini-gastric bypass for revision of failed primary restrictive procedures: a valuable option. Obes Surg. 2007;17(5):684–8.PubMedCrossRef

57.

Rutledge R. Revision of failed gastric banding to mini-gastric bypass. Obes Surg. 2006;16(4):521–3.PubMedCrossRef

Title: “Mini” Gastric Bypass: Systematic Review of a Controversial Procedure
Authors: Kamal K. Mahawar
Neil Jennings
James Brown
Ajay Gupta
Shlok Balupuri
Peter K. Small
Publication date: 01-11-2013
Publisher: Springer US
Published in: Obesity Surgery / Issue 11/2013
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI: https://doi.org/10.1007/s11695-013-1026-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

“Mini” Gastric Bypass: Systematic Review of a Controversial Procedure

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2013

A New Endoscopically Implantable Device (SatiSphere) for Treatment of Obesity—Efficacy, Safety, and Metabolic Effects on Glucose, Insulin, and GLP-1 Levels

Nitric Oxide, Oxidant Status and Antioxidant Response in Morbidly Obese Patients: the Impact of 1-Year Surgical Weight Loss

Laparoscopic Roux-en-Y Gastric Bypass or Laparoscopic Sleeve Gastrectomy as Revisional Procedure after Adjustable Gastric Band—a Systematic Review

A Comment on ‘Changes in Bone Mineral Density in Women Following 1-year Gastric Bypass Surgery’ Published by Casagrande DS et al.

Assessing Psychosocial Functioning of Bariatric Surgery Candidates with the Minnesota Multiphasic Personality Inventory-2 Restructured Form (MMPI-2-RF)

Effects on Glucagon-Like Peptide-1 Secretion by Distal Ileal Administration of Nutrients